These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27732635)

  • 1. Long-Term Prediction of the Demand of Colonoscopies Generated by a Population-Based Colorectal Cancer Screening Program.
    Comas M; Mendivil J; Andreu M; Hernández C; Castells X
    PLoS One; 2016; 11(10):e0164666. PubMed ID: 27732635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-Look Colonoscopies and the Impact on Capacity in FIT-Based Colorectal Cancer Screening.
    Grobbee EJ; Kapidzic A; van Vuuren AJ; van Leerdam M; Lansdorp-Vogelaar I; Looman CW; Bruno MJ; Kuipers EJ; Spaander MC
    Am J Gastroenterol; 2015 Jul; 110(7):1072-7. PubMed ID: 26054624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact on clinical outcomes and healthcare resources from discontinuing colonoscopy surveillance subsequent to low-risk adenoma removal: A simulation study using the OncoSim-Colorectal model.
    Steer KJ; Sun Z; Sadowski DC; Yong JHE; Coldman A; Nemecek N; Yang H
    J Med Screen; 2024 Jun; 31(2):78-84. PubMed ID: 37728194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A direct comparison of the prevalence of advanced adenoma and cancer between surveillance and screening colonoscopies.
    Crispin A; Mansmann U; Munte A; Op den Winkel M; Göke B; Kolligs FT
    Digestion; 2013; 87(3):170-5. PubMed ID: 23635429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of stratifying by family history in colorectal cancer screening programs.
    Goede SL; Rabeneck L; Lansdorp-Vogelaar I; Zauber AG; Paszat LF; Hoch JS; Yong JH; van Hees F; Tinmouth J; van Ballegooijen M
    Int J Cancer; 2015 Sep; 137(5):1119-27. PubMed ID: 25663135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels.
    Toes-Zoutendijk E; van Leerdam ME; Dekker E; van Hees F; Penning C; Nagtegaal I; van der Meulen MP; van Vuuren AJ; Kuipers EJ; Bonfrer JMG; Biermann K; Thomeer MGJ; van Veldhuizen H; Kroep S; van Ballegooijen M; Meijer GA; de Koning HJ; Spaander MCW; Lansdorp-Vogelaar I;
    Gastroenterology; 2017 Mar; 152(4):767-775.e2. PubMed ID: 27890769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.
    Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME
    Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
    Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Impact of the Dutch Colorectal Cancer Screening Program on Cancer Incidence and Mortality-Model-Based Exploration of the Serrated Pathway.
    Greuter MJ; Demirel E; Lew JB; Berkhof J; Xu XM; Canfell K; Dekker E; Meijer GA; Coupé VM
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):135-44. PubMed ID: 26598535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer screening: Estimated future colonoscopy need and current volume and capacity.
    Joseph DA; Meester RG; Zauber AG; Manninen DL; Winges L; Dong FB; Peaker B; van Ballegooijen M
    Cancer; 2016 Aug; 122(16):2479-86. PubMed ID: 27200481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening colonoscopy and colorectal cancer: a single center long term study.
    V Schönfeld J; Müller-Steden B
    Z Gastroenterol; 2016 Apr; 54(4):312-5. PubMed ID: 27056459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonoscopy requirements of population screening for colorectal cancer in New Zealand.
    Green T; Richardson A; Parry S
    N Z Med J; 2012 Jun; 125(1356):85-95. PubMed ID: 22729063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study.
    Jensen CD; Corley DA; Quinn VP; Doubeni CA; Zauber AG; Lee JK; Zhao WK; Marks AR; Schottinger JE; Ghai NR; Lee AT; Contreras R; Klabunde CN; Quesenberry CP; Levin TR; Mysliwiec PA
    Ann Intern Med; 2016 Apr; 164(7):456-63. PubMed ID: 26811150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
    Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
    Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colonoscopy Needs for Implementation of a Colorectal Cancer Screening Program in Ukraine.
    Welten VM; Wanis KN; Semeniv S; Shabat G; Dabekaussen KFAA; Davids JS; Beznosenko A; Suprun U; Soeteman DI; Melnitchouk N
    World J Surg; 2022 Oct; 46(10):2476-2486. PubMed ID: 35835863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of alternative colonoscopy surveillance strategies to mitigate metachronous colorectal cancer incidence.
    Erenay FS; Alagoz O; Banerjee R; Said A; Cima RR
    Cancer; 2016 Aug; 122(16):2560-70. PubMed ID: 27248907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resource implications for a population-based colorectal cancer screening program in Canada: a study of the impact on colonoscopy capacity and costs in London, Ontario.
    Lau A; Gregor JC
    Can J Gastroenterol; 2007 Jun; 21(6):371-7. PubMed ID: 17571171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of advanced colorectal neoplasia in the Thai population: a prospective screening colonoscopy of 1,404 cases.
    Siripongpreeda B; Mahidol C; Dusitanond N; Sriprayoon T; Muyphuag B; Sricharunrat T; Teerayatanakul N; Chaiwong W; Worasawate W; Sattayarungsee P; Sangthongdee J; Prarom J; Sornsamdang G; Soonklang K; Wittayasak K; Auewarakul CU
    BMC Gastroenterol; 2016 Aug; 16(1):101. PubMed ID: 27553627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy.
    Brenner H; Chang-Claude J; Jansen L; Knebel P; Stock C; Hoffmeister M
    Gastroenterology; 2014 Mar; 146(3):709-17. PubMed ID: 24012982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.